WebEmtricitabine was discovered by Emory researchers Dr. Dennis C. Liotta, Dr. Raymond F. Schinazi and Dr. Woo-Baeg Choi and licensed to Triangle Pharmaceuticals by Emory University in 1996. Triangle was acquired by Gilead in 2003. WebMar 27, 2002 · Raymond F. Schinazi, Ph.D., is employed by Emory University as a professor of pediatrics at the Emory School of Medicine, where he both teaches and performs …
COVID-19: Discovery, diagnostics and drug development
WebMay 6, 2024 · Raymond F Schinazi's largest purchase order was 3,464,855 units, worth over $3.19M on April 23, 2015. Raymond F Schinazi's largest sale order was 575,000 units , worth over $1.7M on May 6, 2024. WebDr. Raymond F. Schinaziis the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University and co-Director of the … small vanity mirror with led lights
Raymond F Schinazi PhD - OpenEmory Profile - Emory University
WebRaymond F Schinazi, Frances Winship Walters Professor of Pediatrics, Center for AIDS Research, Emory University School of Medicine, Atlanta, Georgia 30033, USA., ... Weilert F, et al. Phase 1b efficacy and safety of NVR 3-778, a first-in-class HBV core inhibitor, in HBeAg-positive patients with chronic HBV infection. Hepatology. 2015; 62:1385A. WebApr 15, 2014 · Schinazi served on the Presidential Commission on AIDS and is the recipient of numerous awards including the 2006 Distinguished Scientist Award from the Hepatitis … Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, … See more Schinazi was born on March 21, 1950, in Alexandria, Egypt to Jewish parents. In 1962, his family was sequestered by the Nasser regime and in 1964 they immigrated to Naples, Italy as refugees. Schinazi went to … See more Among the first drugs discovered and developed for treatment of HIV came through the collaboration between Dr. Dennis Liotta (Emory) … See more In 2004, Schinazi was one of the founders of Pharmasset, a company that would later go on to develop sofosbuvir. The name Pharmasset was derived from 'pharmaceutical … See more In 2024, Schinazi received the Chevalier de la Légion d’honneur, the French Legion of Honor, with the rank of knight. Established in 1802 by Napoleon … See more Schinazi is currently the Frances Winship Walters Professor of Pediatrics, Director of the Laboratory of Biochemical Pharmacology, and co-Director of the HIV Cure Scientific Working Group within the NIH-sponsored Emory University Center for AIDS Research … See more Schinazi's work led to the discovery of a second nucleoside analog, emtricitabine (FTC), subsequently resulting in a potent, safe nucleoside analog commonly used in treatment regimens. The discovery of FTC was first published in 1992 in Antimicrobial … See more Schinazi has also had a hand in the development of the other FDA-approved drugs Stavudine, Lamivudine, and Telbivudine. See more small vanity mirrors on stands